- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 4.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.9 | - |
NAV | ₹38.59 | - |
Fund Started | 25 Jun 2018 | - |
Fund Size | ₹5507.52 Cr | - |
Exit Load | Exit load of 1% if redeemed within 15 days. | - |
Risk
Very High
-
Rating
4.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.9
-
NAV
₹38.59
-
Fund Started
25 Jun 2018
-
Fund Size
₹5507.52 Cr
-
Exit Load
Exit load of 1% if redeemed within 15 days.
-
Returns
1 Year | 20.37% | - |
3 Year | 29.86% | - |
5 Year | 24.19% | - |
1 Year
20.37%
-
3 Year
29.86%
-
5 Year
24.19%
-
Holding Analysis
Equity | 96.99% | - |
Cash | 3.01% | - |
Equity
96.99%
-
Cash
3.01%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.66% |
Dr. Reddy's Laboratories Ltd. | 9.66% |
Divi's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 7.85% |
Aurobindo Pharma Ltd. | 6.34% |
Alkem Laboratories Ltd. | 4.12% |
Zydus Lifesciences Ltd. | 4.01% |
Lupin Ltd. | 3.98% |
Gland Pharma Ltd. | 3.95% |
Syngene International Ltd. | 2.46% |
-
Fund Manager
Name | Dharmesh Kakkad | - |
Start Date | 23 Feb 2021 | - |
Name
Dharmesh Kakkad
-
Start Date
23 Feb 2021
-
About Fund
Description | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. | - |
Launch Date | 25 Jun 2018 | - |
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
-
Launch Date
25 Jun 2018
-